Molecular Evolution of the Metaplasia-Dysplasia-Adenocarcinoma Sequence in the Esophagus

American Journal of Pathology - United States
doi 10.1016/s0002-9440(10)65346-1
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

MicroRNA-196a Is a Potential Marker of Progression During Barrett's Metaplasia-Dysplasia-Invasive Adenocarcinoma Sequence in Esophagus

American Journal of Pathology
Forensic MedicinePathology
2009English

High-Grade Dysplasia and Intramucosal Adenocarcinoma in Barrettʼs Esophagus

Current Opinion in Gastroenterology
Gastroenterology
2012English

Does the Treatment of Proton Pump Inhibitors Reduce Dysplasia or Adenocarcinoma Development in Barrett's Esophagus?

Turkish Journal of Gastroenterology
Gastroenterology
2017English

Tenascin-C and Fibronectin in Normal Esophageal Mucosa, Barrett’s Esophagus, Dysplasia and Adenocarcinoma

Oncotarget
Oncology
2017English

Expression of Apoptosis-Related Proteins in Barrett's Metaplasia-Dysplasia-Carcinoma Sequence: A Switch to a More Resistant Phenotype

Human Pathology
Forensic MedicinePathology
2002English

Treatment of Squamous Cell and Adenocarcinoma of the Esophagus

Gastrointestinal Cancer: Targets and Therapy
2012English

Adenocarcinoma of the Esophagus With and Without Barrett Mucosa

Archives of Surgery
2000English

The Prevalence of Viral Agents in Esophageal Adenocarcinoma and Barrett’s Esophagus

European Journal of Gastroenterology and Hepatology
HepatologyGastroenterology
2017English

Coexistence of Endometrial Adenocarcinoma With Adenocarcinoma in Situ and Squamous Dysplasia of the Cervix.

The Journal of the Japanese Society of Clinical Cytology
1983English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy